Wintermute Biomedical Inc
Wintermute Biomedical Inc is a cutting-edge biotechnology company based in Missoula, MT, dedicated to developing safe and effective next-generation therapies for infectious diseases. Leveraging their patented platform, they harness the antimicrobial power of fatty acids by solubilizing them in water using amino acids, allowing for a multitude of applications in healthcare.
Their main focus is on developing Solexan, an undecylenic acid-based formulation, as a topical treatment for shingles. With an established safety profile, Wintermute Biomedical is fast-tracking Solexan into efficacy trials and preparing for a Phase I trial to validate its safety in shingles patients. Additionally, they are actively working on novel treatments for antibiotic-resistant diseases, such as Impetigo, to combat drug-resistant bacteria and improve health outcomes for individuals and society at large.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.


